REDWOOD CITY, CA, Jan 7, 2014 (Vantage Health PR) – Vantage Health Inc., (OTCQB: VNTH) and its parent company Nanobeak Inc. today announced that NASA and Nanobeak have entered into an exclusive 5-year license agreement to commercialize mobile healthcare products derived from NASA patented chemical sensing technology. This exclusive 5-year license agreement has been sublicensed to Vantage Health Inc.
Telemedicine and mobile healthcare is formed by the intersection of medicine and digital technology. Nanobeak and Vantage Health have been developing sensor based mobile applications based on patented NASA technology, for non-invasive disease screening at the earliest stages, to be implemented for point of care and individualized healthcare screening using a proprietary breathalyzer attached to a smartphone.
The initial exclusive commercialization agreement with NASA licenses the use of multiple US Patents relating to inventions in the fields of nanotechnology, chemical sensing, carbon nanotubes, medical diagnoses, environmental sensing and cell phone applications. The commercialization agreement requires that the products be manufactured substantially in the United States, and are subject to certain annual royalty payments to NASA. We will use this sensor technology to focus on certain forms of disease screening and narcotics screening. The initial application will be lung cancer.
The sensor technology won the 2012 NASA Government Invention of the Year, which was announced on April 10, 2013. The sensors have been deployed by NASA to detect trace gases in the crew cabin on the International Space Station. Other federal agencies are using sensors based on this technology to detect trace gases in various environments. Specific applications for which the innovative sensors have been tested and used include trace chemical detection in planetary exploration, air monitoring, leak detection and hazardous agent detection using cell phones.
Vantage Health is focused on early screening of lung cancer, colon cancer, breast cancer, prostate cancer and ovarian cancer. We are also developing mobile screening capabilities for medical adherence, heart failure, diabetes, tuberculosis, oxidative stress disorder, metabolic impairment, and HIV/Aids. Cancer is the number two cause of death in America, second only to heart disease according to the Center for Disease Control and Prevention. The World Health Organization statistics indicate that 7.6 million people die from cancer a year — representing more than 20,000 deaths a day.
Commenting on today’s announcement, Jeremy Barbera, Chairman and CEO of Vantage Health, stated, “By analyzing a person’s breath print, the Vantage Health Sensor will provide low cost, non-invasive lung cancer screening for the earliest stages when there are more treatment options available for that person. There were more deaths in 2012 from lung cancer than from prostate, pancreas, breast and colon combined according to the American Cancer Society. The primary reason is that only 15% of lung cancer cases are screened at an early stage — 85% are not.”
“Our mission is to commercialize mobile healthcare technologies that provide physicians and consumers with the tools to better manage the healthcare continuum from managing illness to managing wellness.”
About Vantage Health Inc.
Vantage Health Inc. — a leader in mobile health technology — is developing personalized and point-of-care screening using Apps based upon chemical sensing residing within a small device attached to a smartphone.
With its foundations in advanced nanotechnology, the company’s first product, the Vantage Health Sensor, is the convergence of nano-electronics, bio-informatics, and wireless technology to create the next generation mobile health application.
The first mobile App is expected to be for lung cancer screening with additional mobile healthcare Apps in the planning stages. The company has offices in Redwood City, CA and New York. For more information, please visit http://www.vantagehealthinc.com
Editor’s Note: Below is the NASA press release from April describing the sensor technology:
Ames Honored with Invention Award for Chemical Detection Sensor
MOFFETT FIELD, Calif. - NASA’s Ames Research Center, Moffett Field, Calif., has won the 2012 NASA Government Invention of the Year for a tiny sensor that can detect chemicals in the air.
“High Sensitive, Low Power and Compact Nano Sensors for Trace Chemical Detection” was invented by Jing Li and Meyya Meyyappan of NASA Ames, and Yijang Lu of the University of California, Santa Cruz.
The invention includes methods and systems for estimating one or more unknown parts of a gas using carbon nanotubes. The electronic sensors developed from these carbon nanotubes are inexpensive, light-weight and consume very little power. A typical sensor device based on this concept includes a set of comb-shaped metal microelectrodes fabricated by photolithography on an electrically insulating substrate.
The sensors have been deployed by NASA to detect trace gases in the crew cabin on the International Space Station. Other federal agencies are using sensors based on this technology to detect trace gases in various environments. Specific applications for which the innovative sensors have been tested and used include trace chemical detection in planetary exploration, air monitoring, leak detection and hazardous agent detection using cell phones. Potential future applications may include environmental monitoring, industrial process monitoring and control and biomedical diagnosis.
“We’re very pleased to have Ames inventiveness recognized with this award for the third consecutive year,” said S. Pete Worden, NASA Ames center director. “With this invention, our people have basically created the insides of a tricorder, and based on the uses we’ve already demonstrated, I can’t wait to see the fantastic applications that NASA and industry are going to devise for it.”
Each NASA field center submits nominations for the awards, which are evaluated by NASA’s Inventions and Contributions Board. The board determines which nominations qualify for each category, ranks the nominees, and makes recommendations to the NASA Office of the General Counsel for review and approval.